Araştırma Makalesi

Expression levels of KCNQ1 and KCNQ3 genes in experimental epilepsy model

Cilt: 45 Sayı: 4 27 Aralık 2020
PDF İndir
EN TR

Expression levels of KCNQ1 and KCNQ3 genes in experimental epilepsy model

Abstract

Purpose: Status epilepticus (SE) is a highly common neurological disease in children, with recurrent generalized convulsions for more than 30 minutes, and when not controlled, neuronal damage occurs in the brain. The aim of this study was to evaluate the changes in KCNQ1 and KCNQ3 gene expression levels in the acute period after SE. Materials and Methods: In rats, an experimental SE model was created with Li-Pc. Study; female Wistar albino [250–350 g, 21 (n=7)] rats were used in 3 groups as SE, control and sham groups. The total RNA obtained from brain tissues was converted to cDNA, and gene expression levels of KCNQ1 and KCNQ3 genes were assessed by quantitative real-time PCR (qRT-PCR) method. Results: Statistically in SE group; compared to the control and sham groups, a significant difference was observed in the gene expression levels of the KCNQ1 and KCNQ3 ion channels. The KCNQ1 and KCNQ3 gene expression levels of the experimental group was found higher than the other groups. Conclusion: Determining the changes in mRNA expression levels of genes encoding K+ ion channels will help to better understand the pathological mechanisms that occur during epilepsy. In the SE experimental model created, it is believed that an increase in mRNA expression of KCNQ1 and KCNQ3 will lead to drug therapy studies planned for the future.

Keywords

epilepsy , status epilepticus , KCNQ1 , Li pilocarpine

Kaynakça

  1. Brading AF. Spontaneous activity of lower urinary tract smooth muscles: correlation between ion channels and tissue function. The Journal of physiology.2006;570:13-22.
  2. Lerche H, Jurkat‐Rott K, Lehmann‐Horn F. Ion channels and epilepsy. American journal of medical genetics.2001;106:146-59.
  3. Iannetti P, Farello G, Verrotti A. Editorial–Channelopathies: a link between brain and heart: the model of epilepsy. Eur Rev Med Pharmacol Sci.2017;21:5523-26.
  4. Vizuete AFK, Hennemann MM, Gonçalves CA, De Oliveira DL. Phase-dependent astroglial alterations in Li–pilocarpine-induced status epilepticus in young rats. Neurochemical research. 2017;42:2730-42.
  5. Hitiris N, Mohanraj R, Norrie J, Sills GJ, Brodie MJ. Predictors of pharmacoresistant epilepsy. Epilepsy research.2007;75:192-196. .Hartmann M, Decking UKM. Blocking Na+–H+ exchange by cariporide reduces Na+-overload in ischemia and is cardioprotective. Journal of molecular and cellular cardiology.1999;31:1985-95.
  6. Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, Keating MT. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell.1995;80:805-11.
  7. D'Adamo MC, Catacuzzeno L, Di Giovanni G, Franciolini F, Pessia M. K+ channelepsy: progress in the neurobiology of potassium channels and epilepsy. Frontiers in cellular neuroscience.2013;7:134.
  8. Jespersen T, Grunnet M, Olesen SP. The KCNQ1 potassium channel: from gene to physiological function. Physiology.2005;20:408-16.
  9. Berkovic SF, Mulley JC, Scheffer IE, Petrou S. Human epilepsies: interaction of genetic and acquired factors. Trends in neurosciences.2006;29:391-97.
  10. Rogawski MA. KCNQ2/KCNQ3 K+ channels and the molecular pathogenesis of epilepsy: implications for therapy. Trends in neurosciences.2000;23:393-98.

Kaynak Göster

MLA
Coşkun, Özlem, vd. “Expression levels of KCNQ1 and KCNQ3 genes in experimental epilepsy model”. Cukurova Medical Journal, c. 45, sy 4, Aralık 2020, ss. 1580-6, doi:10.17826/cumj.741811.